These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31489371)

  • 1. Cushing's syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity.
    Walker C; Wang Y; Olivieri C; Karamafrooz A; Casby J; Bathon K; Calebiro D; Gao J; Bernlohr DA; Taylor SS; Veglia G
    Sci Adv; 2019 Aug; 5(8):eaaw9298. PubMed ID: 31489371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?
    Walker C; Wang Y; Olivieri C; V S M; Gao J; Bernlohr DA; Calebiro D; Taylor SS; Veglia G
    J Mol Biol; 2021 Sep; 433(18):167123. PubMed ID: 34224748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
    Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
    Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
    Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
    Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
    Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
    Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
    Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
    Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
    Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome mutant PKA
    Lubner JM; Dodge-Kafka KL; Carlson CR; Church GM; Chou MF; Schwartz D
    FEBS Lett; 2017 Feb; 591(3):459-467. PubMed ID: 28100013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
    Calebiro D; Bathon K; Weigand I
    Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
    Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
    N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A.
    Olivieri C; Wang Y; Walker C; Subrahmanian MV; Ha KN; Bernlohr D; Gao J; Camilloni C; Vendruscolo M; Taylor SS; Veglia G
    Elife; 2024 Jun; 12():. PubMed ID: 38913408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
    Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N
    Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A defects and cortisol-producing adrenal tumors.
    Zilbermint M; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
    Giordano TJ
    Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicine. A unified cause for adrenal Cushing's syndrome.
    Kirschner LS
    Science; 2014 May; 344(6186):804-5. PubMed ID: 24855241
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.
    Sargent J
    Nat Rev Endocrinol; 2014 Jun; 10(6):311. PubMed ID: 24751881
    [No Abstract]   [Full Text] [Related]  

  • 20. Mislocalization of protein kinase A drives pathology in Cushing's syndrome.
    Omar MH; Byrne DP; Jones KN; Lakey TM; Collins KB; Lee KS; Daly LA; Forbush KA; Lau HT; Golkowski M; McKnight GS; Breault DT; Lefrançois-Martinez AM; Martinez A; Eyers CE; Baird GS; Ong SE; Smith FD; Eyers PA; Scott JD
    Cell Rep; 2022 Jul; 40(2):111073. PubMed ID: 35830806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.